Personnel Moves Archives - Page 29 of 42

HeartFlow announces new CEO

HeartFlow announced today that John Farquhar has been appointed as the company’s president and CEO, effective today.

Farquhar, a former Medtronic executive, was appointed as COO of HeartFlow in August 2021 and has served as the company’s president and a member of the board since Jan. 1, 2022.

According to a news release, co-founder and CEO Dr. John H. Stevens will continue to serve on HeartFlow’s board of directors as vice chair after transitioning out of the CEO position.

“On behalf of the entire HeartFlow team, I want to thank John Stevens for his substantial contributions during his tenure as the company’s CEO,” HeartFlow Chairman William C. Weldon said in the release. “As a continuing board member, we will benefit from his drive towards maximizing value for all our stakeholders as we continue to transform the landscape of precision heart care.”

Before joining Mountain View, California-based Hear…

Flex names two new unit presidents

Flex (NSDQ:FLEX) announced earlier this month that it made new appointments to the role of president for two of its business units.

San Jose, California-based Flex confirmed earlier this month that Randy Clark was appointed president of the company’s health solutions business unit, while Rob Campbell was named as president of the company’s consumer devices business unit.

Clark and Campbell will lead the overall vision, strategy, business planning, development and execution of their respective businesses, according to a news release.

With more than 20 years of experience in the medical industry, Clark joins Flex with the responsibility of managing the company’s growing portfolio of medical products and services spanning devices, equipment, drug delivery and more.

He joins Flex from Olympus Corporation of the Americas, having most recently served on the board of directors and executive committee and as the company’s president…

Pavmed appoints Shaun O’Neil as chief operating officer

Pavmed (NSDQ:PAVM) this week appointed Shaun O’Neil as executive VP and chief operating officer.

O’Neil has served as Pavmed’s chief commercial officer and executive VP of business development since joining the company in 2018. Through his new roles, he will be responsible for overseeing diverse corporate operations and commercial activities within Pavmed and its subsidiaries. He will serve on the company’s executive committee as an executive officer.

“I am energized to take on this expanded role at such an exciting time for PAVmed and its subsidiaries,” O’Neil said. “We are in as strong a position as ever to execute on our strategic plan, drive commercialization of our products and grow long-term shareholder value. That strength is built on a solid balance sheet, groundbreaking technologies, and the best team in the industry. I look forward to helping execute on our vision to transform PAVmed into a leading global medical technolo…

BD appoints Shana Neal as chief people officer

BD (NYSE:BDX) this week announced that it appointed Shana Neal as chief people officer, effective April 4.

Neal will oversee the Franklin Lakes, N.J.-based company’s human resources, communications and social investing functions globally, including talent acquisition and management; total rewards; HR operations; HR business partnering and inclusion, diversity, equity and engagement.

Prior to becoming chief people officer, Neal held numerous human resources leadership positions at BD between 2005 and 2018. She then joined Owens & Minor as executive VP and chief human resources officer in 2018, where she also served as president of the Owens & Minor Foundation and the executive sponsor for Environmental, Social and Governance initiatives.

Neal replaces Betty Larson who was named to a new role in the healthcare industry, according to the company. Neal will report to BD chairperson, CEO and president Tom Polen.

“Shana’s highl…

Smith+Nephew rises on Q4 earnings, announces new CEO

Smith+Nephew (NYSE:SNN) shares ticked up today as it announced a new CEO along with its quarterly earnings.

Shares of SNN were up 6.4% at $34.67 per share in late-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%.

The company confirmed that Dr. Deepak Nath will succeed Roland Diggelmann in the role of CEO after Diggelmann steps down, a move that will be made as a result of a mutual agreement.

Nath will begin as CEO on April 1, 2022, after Diggelmann departs on March 31, 2022, according to a news release.

“It has been a privilege to lead Smith+Nephew,” Diggelmann said in the release. “I would like to thank my colleagues across the business for their tireless efforts to support our customers and communities, and continue to deliver against the backdrop of COVID. I look forward to seeing the business go from strength to strength under Dee…

Johnson & Johnson adds Honeywell CEO to its board

Honeywell CEO Darius Adamczyk [Image courtesy of Honeywell]Honeywell CEO Darius Adamczyk will join Johnson & Johnson’s board of directors, the medtech and pharma giant announced.

In a news release posted yesterday, J&J CEO Alex Gorsky described Adamczyk as an “accomplished global leader with decades of experience and a track record of growing businesses.”

“He is also a champion of sustainability and investments in innovation to improve the lives of people around the world,” Gorsky said. “Darius’s extensive knowledge of numerous business sectors will add important dimension and a unique perspective to the Johnson & Johnson Board of Directors.”

Adamczyk joined Honeywell in 2008 after Honeywell acquired when laser and scanning technology company Metrologic, where he was CEO. Since then, he has risen through the executive ranks at Honeywell, taking over the corner office in 2017.

Insulet appoints Elizabeth Weatherman to board of directors

Insulet (NSDQ:PODD) announced that Elizabeth (Bess) Weatherman was appointed to its board of directors.

Weatherman will stand for election by stockholders at the company’s 2022 annual meeting and has been named to the board’s Compensation Committee.

Get the full story at our sister site, Drug Delivery Business News.

MassMEDIC announces board additions

The Massachusetts Medical Device Industry Council (MassMEDIC) today announced the appointment of eight new members to its board of directors.

Joseph Ferrara, Michelle Fox, Brent Fullerton, Chris Killburn-Peterson, Jaydeo Kinikar, Sonal Patel, Stacey Pugh and Adam Sachs have all joined the MassMEDIC board.

“We are honored to welcome our new members to our Board of Directors to further the mission of saving and improving the lives of patients everywhere through medical technology,” MassMEDIC President Brian Johnson said in a news release. “Their dedication to continuous improvement of our healthcare ecosystem in Massachusetts and New England, paired with their industry expertise, will strengthen our community built on collaboration and collaborative success.”

Ferrara serves as chief innovation officer at Veranex and holds more than 25 years of experience in the medtech industry. Fox, who is CMO at Teleflex, offers vast experience in clinical affairs and…

Collagen Matrix appoints former Stryker president Scannell to its board

[Image from Collagen Matrix]Collagen Matrix announced today that it appointed former Stryker executive Timothy J. Scannell to its board of directors.

Oakland, New Jersey-based Collagen Matrix develops regenerative medicine and manufactures collagen- and mineral-based medical devices.

Scannell, a veteran of 30 years in leadership positions, joins the company after serving as president and COO of Stryker, a position he retired from in August 2021. Stryker said at the time that Scannell would officially transition from the role on Oct. 1, 2021, and act as an advisor to Stryker CEO Kevin Lobo until his official retirement date set for March 31, 2023.

During the earlier stages of his career, Scannell led Stryker’s neurotechnology, spine and medsurg business and served as GM of the company’s biotech division. He also serves as the chair of Insulet’s board of directors and is on the board of directors for Novocure.

“Tim’s appoi…

Smart bone growth company Intelligent Implants announces CEO

Intelligent Implants’ new CEO Benjamin Hertzog

Digital medicine and orthopedics startup Intelligent Implants announced that it has brought on Benjamin A. Hertzog as its CEO

Hertzog was most recently Entrepreneur in Residence with Johnson and Johnson’s Center for Device Innovation at the Texas Medical Center. He previously was founding CEO of catheter-deployed heart pump developer Procyrion, which he led through a Series C financing.

“Ben joined Intelligent Implants as Executive Chairman of the Board in 2020, and his broad experience in complex Class-III medical devices, leadership, and exceptional track record made it an obvious choice to have Ben join us at the helm of the company,” said John Zellmer, Intelligent Implants’ co-founder and founding CEO.

“Ben has the skills and credibility to guide Intelligent Implants as we navigate through the next stage of clinical and commercial activities, Zellmer added in a news release that posted yester…

BioVentrix expands heart failure treatment portfolio with MateraCor acquisition

BioVentrix announced today that it has acquired MateraCor, a company developing injectable alginate-based hydrogel to treat heart failure.

San Ramon, Calif.–based BioVentrix is a privately held medical device company focused on less invasive therapies to treat the left ventricle.

The financial terms of the deal were not disclosed.

“This is an exciting time for BioVentrix as we build a platform of synergistic therapies to treat a dilated left ventricle, the root cause of ischemic and idiopathic heart failure,” BioVentrix CEO Jim Dillon said in a news release.

Dillon added that buying MateraCor and its lead Trans-Catheter Myocardial Restoration (TCMR) product reinforces BioVentrix’s position to treat left ventricular heart failure with a variety of products and services.

Also today, BioVentrix announced the appointment of Steve Chartier, former VP of global clinical affairs at liver cancer therapies company Sirtex Medical, as the compan…

Activ Surgical appoints former Olympus VP as its COO

Activ Surgical announced today that it appointed Manisha Shah-Bugaj as its new chief operating officer (COO).

Shah-Bugaj will hold responsibility for overseeing all business operations for the company, including oversight of the impending commercialization of its ActivSight enhanced visualization imaging model and the implementation of its surgical visualization technology at established pilot hospital sites in 2022.

“I am thrilled to join the Activ Surgical team and to have the opportunity to play a critical role in ushering in a new paradigm of surgical care with advanced surgical visualization technology,” Shah-Bugaj said in a news release. “My personal and professional values are very much aligned with the company’s mission to democratize world-class surgical care, and, ultimately, to save lives by eliminating complications in the operating room. I have been nothing but impressed with [CEO Todd Usen] and the leadership team at Activ Surgical and look forwar…